Portfolio company Tavros Therapeutics achieved acquisition.
Tavros Therapeutics is a precision oncology platform company that leverages next-generation functional and computational genomics technology to uncover unique vulnerabilities within tumors to discover novel targets and biomarkers in areas of high unmet clinical need
Tavros Therapeutics is a precision oncology platform company that leverages next-generation functional and computational genomics technology to uncover unique vulnerabilities within tumors to discover novel targets and biomarkers in areas of high unmet clinical need.